Boston Scientific CorporationBSXNYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+18.8%
5Y CAGR+14.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+18.8%/yr
vs +5.6%/yr prior
5Y CAGR
+14.7%/yr
Recent acceleration
Acceleration
+13.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $9.88B | +29.5% |
| 2024 | $7.63B | +14.8% |
| 2023 | $6.65B | +12.9% |
| 2022 | $5.89B | +6.3% |
| 2021 | $5.54B | +11.3% |
| 2020 | $4.97B | -3.7% |
| 2019 | $5.17B | +9.0% |
| 2018 | $4.74B | +9.1% |
| 2017 | $4.35B | +5.8% |
| 2016 | $4.11B | - |